[HTML][HTML] Nanoparticle biodistribution coefficients: A quantitative approach for understanding the tissue distribution of nanoparticles

M Kumar, P Kulkarni, S Liu, N Chemuturi… - Advanced Drug Delivery …, 2023 - Elsevier
The objective of this manuscript is to provide quantitative insights into the tissue distribution
of nanoparticles. Published pharmacokinetics of nanoparticles in plasma, tumor and 13 …

Integration of in vitro and in vivo models to predict cellular and tissue dosimetry of nanomaterials using physiologically based pharmacokinetic modeling

Z Lin, S Aryal, YH Cheng, AJ Gesquiere - ACS nano, 2022 - ACS Publications
Nanomaterials (NMs) have been increasingly used in a number of areas, including
consumer products and nanomedicine. Target tissue dosimetry is important in the evaluation …

Current approaches and techniques in physiologically based pharmacokinetic (PBPK) modelling of nanomaterials

W Utembe, H Clewell, N Sanabria, P Doganis… - Nanomaterials, 2020 - mdpi.com
There have been efforts to develop physiologically based pharmacokinetic (PBPK) models
for nanomaterials (NMs). Since NMs have quite different kinetic behaviors, the applicability …

Physiologically based pharmacokinetic modeling of nanoparticle biodistribution: a review of existing models, simulation software, and data analysis tools

EO Kutumova, IR Akberdin, IN Kiselev… - International Journal of …, 2022 - mdpi.com
Cancer treatment and pharmaceutical development require targeted treatment and less toxic
therapeutic intervention to achieve real progress against this disease. In this scenario …

Emerging investigator series: perspectives on toxicokinetics of nanoscale plastic debris in organisms

FA Monikh, MG Vijver, R Kortet, I Lynch… - Environmental …, 2022 - pubs.rsc.org
Fragmentation of plastic waste in the environment can lead to the formation of nanoscale
plastic debris (NPD) of size< 1 μm. Although it is reported that NPD can be taken up by …

Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling of Nanomaterials

O Ozbek, DE Genc, K O. Ulgen - ACS Pharmacology & …, 2024 - ACS Publications
Nanoparticles (NPs) have been widely used to improve the pharmacokinetic properties and
tissue distribution of small molecules such as targeting to a specific tissue of interest …

A new pharmacokinetic model describing the biodistribution of intravenously and intratumorally administered superparamagnetic iron oxide nanoparticles (SPIONs) in …

AP Klapproth, M Shevtsov, S Stangl, WB Li… - International Journal …, 2020 - Taylor & Francis
Background Superparamagnetic iron oxide nanoparticles (SPIONs) have displayed
multifunctional applications in cancer theranostics following systemic delivery. In an effort to …

The LEAP process: streamlining the development of long-acting products and formulations for infectious diseases

C Flexner, M Siccardi, F Bunglawala… - Clinical Infectious …, 2022 - academic.oup.com
Developing long-acting products and formulations for infectious diseases is a nontrivial
undertaking that is frequently classified as high risk and low reward by the pharmaceutical …

A quantitative systems pharmacology (QSP) platform for preclinical to clinical translation of in-vivo CRISPR-Cas therapy

DA Desai, S Schmidt, R Cristofoletti - Frontiers in Pharmacology, 2024 - frontiersin.org
Background: In-vivo CRISPR Cas genome editing is a complex therapy involving lipid
nanoparticle (LNP), messenger RNA (mRNA), and single guide RNA (sgRNA). This novel …

An assessment of applicability of existing approaches to predicting the bioaccumulation of conventional substances in nanomaterials

W Utembe, V Wepener, IJ Yu… - … toxicology and chemistry, 2018 - Wiley Online Library
The experimental determination of bioaccumulation is challenging, and a number of
approaches have been developed for its prediction. It is important to assess the applicability …